Ketamine Infusion Malpractice Insurance GET QUOTEhttps://medpli.com/wp-content/uploads/2021/01/doctor-holding-clipboard-interviewing-casually-dressed-male-patient.jpg Ketamine Infusion Therapy is considered high risk, and medical practices that offer it need specialized malpractice insurance policies. Over the past decade, research on using ketamine as an alternative treatment to medication-resistant mental health disorders and chronic pain has been on the rise. The number of health professionals recognizing the medical benefits of Ketamine infusions has increased, and from 2015 to 2018 alone, the number of clinics specializing in Ketamine Infusion Therapy grew from 60 to 300. If you are a medical professional offering Ketamine infusions through your private practice or a specialized clinic, your existing malpractice policy likely doesn't cover it. An independent medical malpractice insurance broker like MEDPLI is the best way to obtain additional A-rated, competitively priced coverage that is tailored to your practice’s unique needs. Get Quote Liability Insurance Information and Rates for Ketamine Infusion Clinics The right medical malpractice insurance will protect healthcare providers from monetary damages and attorney’s fees in the event of a lawsuit. There are a variety of policies available for Ketamine Infusion Therapy. MEDPLI recommends purchasing a Claims-made or Occurrence form policy, rather than a claims-paid policy. The below estimated annual costs are for information purposes only and based on $1,000,000 per claim / $3,000,000 aggregate limits of liability. Your unique practice needs a custom quote to know the exact costs of your medical professional liability coverage. To get your personalized rate estimate from MEDPLI, please request a quote. Clinic Volume Premium Estimate Low-volume startup Ketamine Therapy Clinic $5,000-$10,000 Mid-sized Ketamine Therapy Clinic $10,000-$20,000 Large Ketamine Therapy Clinic $25,000+ Why You Need Additional Malpractice Insurance for Ketamine Infusion Therapy Ketamine Infusion Therapy is used off-label and is not approved by the FDA. Ketamine was approved by the FDA for use in anesthesia in 1970. Today, patients are seeking ketamine infusion therapy treatments for chronic pain and medication-resistant mental health disorders such as depression, PTSD, and anxiety. Medical Directors, doctors, nurse practitioners, physician’s assistants, anesthesiologists, nurse anesthetists, psychiatrists, PMH nurses, psychotherapists, and other healthcare professionals have started to offer single or multiple session IV ketamine infusions through private clinics or their small and large group medical practices. Patients generally pay out of pocket for this service – most insurers do not cover Ketamine Therapy because of its off label-use. Using medication off-label comes with increased risk, and the expanded availability of Ketamine Infusion Therapy over the past few years has led to the emergence of ketamine-related medical malpractice lawsuits. Ketamine Infusion Therapy is also considered high risk because: the FDA lacks oversight of the process since the medication is used off-label multiple existing federal and state laws and regulations apply to clinics, including who can own and operate them there isn’t much data available on the long-term effects or potential risks there is no clear consensus on best practices – including who qualifies for treatment, optimal dosing, and the type of medical care that should be offered concurrently there are conflicting opinions about who should participate on a patient’s treatment team before, during, and after Ketamine Therapy (including who should administer the infusion) GET QUOTE Get a fast quote for ketamine infusion malpractice insurance.